• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Microbiology and Immunology
    • View Item
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Microbiology and Immunology
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia

    Thumbnail
    View/ Open
    McCubreyHealthyCD4TLymphocytesarenotaffectedbytargetedtherapies.pdf (2.490Mb)

    Show full item record
    
    Author
    McCubrey, James A.
    URI
    http://hdl.handle.net/10342/9592
    Subject
     T lymphocytes; PI3K/Akt/mTOR signaling; T-acute lymphoblastic leukemia 
    Date
    2016-08-23
    Citation:
    APA:
    McCubrey, James A.. (August 2016). Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia. Oncotarget, (7:34), p.. Retrieved from http://hdl.handle.net/10342/9592

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    McCubrey, James A.. "Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia". Oncotarget. 7:34. (.), August 2016. May 23, 2022. http://hdl.handle.net/10342/9592.
    Chicago:
    McCubrey, James A., "Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia," Oncotarget 7, no. 34 (August 2016), http://hdl.handle.net/10342/9592 (accessed May 23, 2022).
    AMA:
    McCubrey, James A.. Healthy CD4+ T Lymphocytes are Not Affected by Targeted Therapies Against the PI3K/Akt/mTOR Pathway in T-cell Acute Lymphoblastic Leukemia. Oncotarget. August 2016; 7(34) . http://hdl.handle.net/10342/9592. Accessed May 23, 2022.
    Collections
    • Microbiology and Immunology

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback